An interventional study of Endovenous Laser ablation and concomitant phlebectomies and Endovenous Laser ablation and sequential phlebectomies in Varicose Veins, Endovenous Laser Ablation and Phlebectomies, sponsored by Hull University Teaching Hospitals NHS Trust. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-07-26.
Sponsored by Hull University Teaching Hospitals NHS Trust · Not applicable, Interventional, and Treatment
Varicose veins of the leg often have superficial tributaries, which are often symptomatic and a major reason for coming to the doctor. When treating the main varicose vein inside the leg, some doctors prefer to remove these tributaries while others prefer to leave them. This trial aims to see if it is better to remove these veins at the time of the first laser procedure or better to leave them and only remove them when asked.
Endovenous laser therapy (EVLT) for varicose veins is associated with high initial occlusion rates, minimal complications and low recurrence rates at 5 years. Randomized trials and meta-analyses have confirmed the efficacy of EVLT in comparison with surgery and other endovenous techniques. There is also evidence that it may be associated with early quality of life (QoL) benefits compared with surgery. The general efficacy of EVLT has therefore been demonstrated and current research focuses on refinement of the procedure. A fundamental question concerns the management of residual varicosities following truncal laser ablation. One approach is to leave these varicosities to regress untouched, minimizing the procedure time and surgical trauma6. This approach, however, is associated with a significant number of secondary and tertiary interventions (sclerotherapy and/or ambulatory phlebectomy). Another option is to combine in a single procedure ambulatory phlebectomy with initial truncal laser ablation (EVLTAP). The aim of this randomized controlled trial was to assess the advantages of performing ambulatory phlebectomy as a concomitant procedure to truncal laser ablation.
253 studies on the registry are indexed under Varicose Veins; 35 are open to participants now.
This study's enrollment of 50 is below the median of 104 across 162 interventional studies indexed under Varicose Veins.
Browse Varicose Veins studies →Hull University Teaching Hospitals NHS Trust is the lead sponsor of 93 studies on the registry; 15 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Removal of varicose tributaries during Endovenous laser ablation
Procedure: Endovenous Laser ablation and concomitant phlebectomies · Procedure: Endovenous Laser ablation and sequential phlebectomies
Endovenous laser ablation only
Procedure: Endovenous Laser ablation and concomitant phlebectomies · Procedure: Endovenous Laser ablation and sequential phlebectomies
Disease specific QoL (AVVQ)
Time frame: 5 years
Number of secondary procedures
Time frame: 5 years
This study is completed, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hull University Teaching Hospitals NHS Trust